NCT05881980View on ClinicalTrials.gov

Efficacy and Safety of Terbinafine and Itraconazole

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

October 31, 2023

Study Completion Date

November 30, 2023

Conditions
Tinea CorporisTinea CrurisTinea FacieiDermatophytoses
Interventions
DRUG

Terbinafine Tablets

Terbinafine 250 mg/day

DRUG

Itraconazole

Itraconazole 200 mg/day

Sponsors
All Listed Sponsors
lead

Dhaka Medical College

OTHER